Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3Phase 1/2 3Phase 1 2Phase 2/3 1

Status

Active not recruiting 3Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4

Conditions

Breast Neoplasms 88Carcinoma, Non-Small-Cell Lung 86Multiple Myeloma 73Prostatic Neoplasms 63Neoplasms 55Colorectal Neoplasms 46Lymphoma 42Squamous Cell Carcinoma of Head and Neck 41Leukemia, Myeloid, Acute 41Lung Neoplasms 39Pancreatic Neoplasms 32Neoplasm Metastasis 32Carcinoma, Hepatocellular 31Ovarian Neoplasms 30Lymphoma, Large B-Cell, Diffuse 29Carcinoma, Renal Cell 29Urinary Bladder Neoplasms 28Lymphoma, Non-Hodgkin 27Melanoma 26Head and Neck Neoplasms 26Hematologic Neoplasms 25Triple Negative Breast Neoplasms 24Sarcoma 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Hodgkin Disease 23Leukemia, Lymphocytic, Chronic, B-Cell 22Glioma 22Stomach Neoplasms 20Myelodysplastic Syndromes 20Lymphoma, Mantle-Cell 19

Interventions

Magnetic Resonance Spectroscopy 2talimogene laherparepvec 1ribociclib 1pembrolizumab 1palbociclib 1cemiplimab 1Specimen Handling 1Radiotherapy 1Radiation 1Immunoglobulin G 1Everolimus 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Liposarcoma × 30 days × Clear all
NCT03114527 2026-05-22

Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

Fox Chase Cancer Center

Phase 2 Active not recruiting
48 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

NCT07089992 2026-05-14

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
32 enrolled
Sarcoma

Liposarcoma, Sarcoma, Perivascular Epithelioid Cell Neoplasms

NCT02923778 2026-05-13

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT05694871 2026-05-11

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
77 enrolled
Sarcoma

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡